Multinational firms urged to compensate returned goods

Despite the price cuts in January, six multinational drug manufactures decided not to compensate any returned goods sold before March, it was learned by an emergency council of the Korean Pharmaceutical Wholesaler Association at a meeting at Daejeon on Mar. 6.

These firms are Invida Korea, JS Pharma, Sanofi-Aventis, Daiichi-Sankyo, Takeda and AstraZeneca Korea.

Furthermore, Novo Nordisk, ...